SHMN - SOHM, INC
SHMN Business Description
SOHM, Inc. produces and markets generic pharmaceutical products for various treatment
categories. It offers its products in various dosage forms, including tablets and capsules,
creams and topicals, ointments, liquids, and injectables.
The company has licenses to manufacture 30 products and approximately
300 generic drugs and product formulations for distribution. It offers generic pharmaceutical
products in the areas of anti-arthritic/analgesics, anticancer drugs, antifungals, anti-infectives,
cardiovascular agents, central nervous system, dermatological, gastrointestinal and
respiratory drugs, biotechnology products, hormones, anesthetics, antidiabetics, antiemetics,
dermatologicals, immunosuppressive agents, ophthalmic drugs, and treatments for benign
prostatic hyperplasia.
The company markets its products directly and through partner alliance agreements to
drug wholesalers, mass merchandisers, warehousing chain drug stores, and mail-order
pharmacies primarily in the Far East, Africa, European Union, Southeast Asia, and Latin America. SOHM, Inc. was founded in 2005 and is headquartered in Buena Park, California.
Manufacturing Hub
categories. It offers its products in various dosage forms, including tablets and capsules,
creams and topicals, ointments, liquids, and injectables.
The company has licenses to manufacture 30 products and approximately
300 generic drugs and product formulations for distribution. It offers generic pharmaceutical
products in the areas of anti-arthritic/analgesics, anticancer drugs, antifungals, anti-infectives,
cardiovascular agents, central nervous system, dermatological, gastrointestinal and
respiratory drugs, biotechnology products, hormones, anesthetics, antidiabetics, antiemetics,
dermatologicals, immunosuppressive agents, ophthalmic drugs, and treatments for benign
prostatic hyperplasia.
The company markets its products directly and through partner alliance agreements to
drug wholesalers, mass merchandisers, warehousing chain drug stores, and mail-order
pharmacies primarily in the Far East, Africa, European Union, Southeast Asia, and Latin America. SOHM, Inc. was founded in 2005 and is headquartered in Buena Park, California.
Manufacturing Hub
India has a significant share in the global generics market and is ranked third in the world.
Three factors favoring the company’s manufacturing hub in India are a strong marketing set up,
low prices and the advantage of using the English language. With domestic drug sales of almost
$5 billion, Indian companies have also developed a considerable service industry for the
global pharmaceutical market.
Emerging Markets – Focus on High Growth
Growth is shifting away from developed markets in the U.S. and Europe and toward emerging markets
as less developed countries prosper and spend more money on health care.
SOHM’s Growth Strategy – Emerging Markets Leader
Increasing SOHM’s market share in key markets, including an extension of its leadership position
in the world’s emerging generic pharmaceutical markets in Africa, Latin America, Southeast Asia
and other important international markets.
Rapidly responding to customers’ most significant needs by – among others—broadening SOHM’s
product portfolio and executing an increasing number of launches, optimizing a truly global supply chain,
helping customers more efficiently manage their inventory and customizing shipping methods based on
specific customer needs.
Products and Services
Pharmaceutical Products
SOHM Brand
Generic pharmaceuticals are the chemical and therapeutic equivalents of brand-name drugs
and are typically sold under their chemical names at prices substantially
below those of the brand-name pharmaceuticals.
Generics are required to meet similar governmental regulations as their brand-name equivalents
and must receive regulatory approval prior to their sale in any given country.
Generic pharmaceuticals are benefiting from increasing awareness and acceptance on the part of
consumers, physicians and pharmacists globally.
Factors contributing to this increased awareness are the passage of legislation permitting or encouraging
substitution and the publication by regulatory authorities of lists of
equivalent pharmaceuticals, which provide physicians and pharmacists with generic alternatives.
SOHM believes that these factors, together with an aging population and a corresponding increase in
healthcare costs, as well as the large number of branded products losing patent protection over the
coming years, should lead to continued global expansion of the generic pharmaceuticals market.
Products http://www.sohm.com/pharmaceutical-products/
and are typically sold under their chemical names at prices substantially
below those of the brand-name pharmaceuticals.
Generics are required to meet similar governmental regulations as their brand-name equivalents
and must receive regulatory approval prior to their sale in any given country.
Generic pharmaceuticals are benefiting from increasing awareness and acceptance on the part of
consumers, physicians and pharmacists globally.
Factors contributing to this increased awareness are the passage of legislation permitting or encouraging
substitution and the publication by regulatory authorities of lists of
equivalent pharmaceuticals, which provide physicians and pharmacists with generic alternatives.
SOHM believes that these factors, together with an aging population and a corresponding increase in
healthcare costs, as well as the large number of branded products losing patent protection over the
coming years, should lead to continued global expansion of the generic pharmaceuticals market.
Products http://www.sohm.com/pharmaceutical-products/
Friday, January 27, 2012
Marketwire (Fri 5:00AM EST)
Friday, January 20, 2012
Marketwire (Fri, Jan 20)
Wednesday, January 18, 2012
Marketwire (Wed, Jan 18)
Wednesday, November 23, 2011
Marketwire (Wed, Nov 23)
Shailesh Shah, CEO of SOHM Inc, - SHMN announces the acquisition of Navatrend
Monday, November 14, 2011
Marketwire (Mon, Nov 14)
SOHM 3Q Results, Presidents Message
A Message from the President of SOHM
Thursday, November 3, 2011
Marketwire (Thu, Nov 3)
Monday, September 12, 2011
Marketwire (Mon, Sep 12)
Friday, August 5, 2011
Marketwire (Fri, Aug 5)
Tuesday, August 2, 2011
Products Company Acquisition Marketwire (Tue, Aug 2)
Management Team
Mr. Shailesh Shah , 46
Chairman, Chief Exec. Officer, Pres, Chief Exec. Officer of US, India & Global Operations
and Pres of US, India & Global Operations
Mr. L. Dee Hall , 66
Chief Operating Officer
Ms. Swati Shah ,
VP, Sec., Treasurer and Director
Mr. Sanjiv Bosamia ,
Chief Exec. Officer of Dermatology and Cosmeceutical Division
Mr. Shaunak Parikh ,
VP of Operations
Contact Us
Sohm Worldwide
Corporate Office
6920 Knott Avenue, Suite A-C, Buena Park, CA 90621 USA
Phone: 1 (714) 522-6700
Fax: 1 (714) 523-4329
Website: www.sohm.com
Email: info@sohm.com
Phone: 1 (714) 522-6700
Fax: 1 (714) 523-4329
Website: www.sohm.com
Email: info@sohm.com
India Office
Sohm India Private Limited 302 & 303, Third Floor, Rembrandt Above CITI Bank C.G. Road, Ahmedabad - 380-006
Website: www.sohmindia.com
Email: business@sohmindia.com
Website: www.sohmindia.com
Email: business@sohmindia.com
UK Office
China office
As Always: Our Number 1 Priority is to educate. Penny stocks are very volatile, Always do your own Due Diligence
Sources: otcmarket.com, www.bloomberg.com, www.finance.yahoo.com, www.businessweek.com (these are only sources and not always up to date) This alert brought to you by SizzlingStockPicks
Follow Us on Twitter https://twitter.com/#!/SizzlinStockPix
Follow Us on Facebook http://www.facebook.com/groups/SizzlingStockPicks/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.